From 8 January 2019, the EU Council Directive 2013/59/Euratom, which sets basic safety standards for protection arising from exposure to ionising radiation, has been transposed into Irish law. This legislation has designated HIQA as the independent competent authority for medical exposures.

Every day, people are exposed to both natural and artificial sources of radiation and radioactivity.  Natural sources include radon and cosmic radiation, while artificial or man-made sources include medical ionising radiation and residual nuclear contamination. Radiation exposure from natural sources is difficult to eliminate; however, appropriate controls and regulation of the use of ionising radiation can help reduce or prevent inappropriate medical exposures.

From 8 January 2019, the EU Council Directive 2013/59/Euratom, which sets basic safety standards for protection arising from exposure to ionising radiation, has been transposed into Irish law. This legislation has designated HIQA as the independent competent authority for medical exposures. The purpose of HIQA’s ionising radiation (medical exposures) regulatory and health technology assessment programmes is to promote better, safer practice across all service providers using medical exposures in Ireland.

Service providers may include public hospitals, private hospitals, private clinics, dentists and any other facility that used ionising radiation for medical exposures.

SAMIRA-PrISMA

HIQA is one of 18 organisations from 12 European countries taking part in the PrISMA (Preparatory activities to support Implementation of quality and Safety of Medical ionising radiation Applications) project. HIQA is contributing to Work Package 4/Sustainability and Work Package 5/Technical.

The SAMIRA action plan is the EU’s first comprehensive plan to support the safe, high-quality and reliable use of radiological and nuclear technology in healthcare.

The PrISMA project is coordinated by the National Institute for Public Health and the Environment in the Netherlands, and has two key objectives:

  • to map the relevant actors in Member States and conduct network activities to promote future initiatives
  • to jointly produce a proposal for a future Joint Action in the area of quality and safety of medical applications of ionising radiation, including objectives, scope and activities.

Funding
This project has received co-funding from the European Commission, EU4Health Programme 2021-2027, under grant agreement No. 101162826. 

europen co-funded logo